Article
Novotech Joins DTRA
Novotech Health Holdings Pte. Ltd. (“Novotech”) has joined an alliance of over one hundred life sciences and healthcare organizations that seek to accelerate the broad adoption of patient-focused, decentralized trials, and research. The “Decentralized Trials & Research Alliance (DTRA),” launched in December 2020, is uniting industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
